Drug intelligence / Profile preview

Changyanning

Development stage
Phase 4
Lead developer
Conba Pharmaceutical
Administration
Oral
01

Overview

Changyanning is a Traditional Chinese Medicine (TCM) formulation widely used in China for the treatment of various gastrointestinal disorders. The preparation is typically composed of five herbal ingredients: Brocade herb (*Euphorbia humifusa*), *Hedyotis flavescens*, Camphor roots, Chinese elsholtzia, and Maple leaves. It is indicated for acute and chronic gastroenteritis, diarrhea, bacterial dysentery, and pediatric dyspepsia. Mechanistically, Changyanning exhibits anti-inflammatory and antioxidant properties; it has been shown to reduce the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, decrease myeloperoxidase (MPO) activity, and enhance intestinal epithelial barrier function by upregulating tight junction proteins like occludin and ZO-1. Clinical research has expanded its application to include diarrhea-predominant irritable bowel syndrome (IBS-D), functional diarrhea, and the management of symptoms following endoscopic resection of colorectal polyps.

Brand names
ChangyanningKang'enbei Changyan Ning
Other names
Chang-Yan-NingChangyanning TabletChangyanning GranuleChangyanning Capsule
02

Targets

Misfolded SOD1IL-6 (Interleukin 6)CLDN1 (Tight junction protein claudin-1)MPO (Myeloperoxidase)TJP1 (Tight junction protein 1 (ZO-1))IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))OCLN (Occludin)

Beyond the preview

Go deeper on Changyanning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changyanning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call